Last reviewed · How we verify
NCT04919434
Intervention to Reduce Exposure to Environmental COntaminant (IRECO)
NA trial testing IRECO in Exposure in 107 participants. Participants enrolled and being followed up; not accepting new ones.
16 July 2024
Quick facts
| Lead sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 107 |
| Start date | 26 June 2022 |
| Primary completion | 16 July 2024 |
| Estimated completion | 25 June 2027 |
| Sites | 1 location across France |
Drugs / interventions tested
- IRECO
Conditions studied
- Exposure — all drugs for Exposure →
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France — full company profile →
Who can join
Adults 18 to 30, female only, with Exposure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Main objective The intervention study IRECO aims to (1) modify habits of personal care product use for the participants and (2) evaluate the impact of those modification on urinary concentration for the following compounds: phthalates, phenols and glycol ether. Secondary objectives: The secondary objectives of this study aim to evaluate: 1. impact of modification of personal care product on the levels of biomarkers linked to exposure to environmental pollutant other than phthalates phenol and glycol ether (untargeted analysis) and biomarkers related to health (such as inflammatory biomarkers and oxidative stress). 2. hazard perception linked to the exposure to chemical product present in personal care product 3. barriers to change habits allowing to decrease exposure to environmental pollutant on short and long term as well as levers allowing to remove those barriers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04919434
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Exposure
Currently open trials in the same condition.
- NCT06477627 — The Coastal Exposome: a Study of Sea Air Inhalation and Possible Links to Health · NA · active not recruiting
- NCT06323538 — Cohort Study on Plant-based Diets (COPLANT Study) · recruiting
- NCT05869747 — Firefighter Collaborative Research Project · NA · active not recruiting
- NCT05079984 — Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain · NA · active not recruiting
Other Institut National de la Santé Et de la Recherche Médicale, France trials
Trials by the same sponsor.
- NCT07311213 — GENES AND AUTISM - IPSC · NA · not yet recruiting
- NCT07063719 — Identification of Cellular Biomarkers of Rare Eye Diseases in Adults · NA · not yet recruiting
- NCT06906042 — Multimodal Cardiovascular and Hepatic Population Imaging · recruiting
- NCT06951035 — Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke · NA · not yet recruiting
- NCT06660108 — MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04919434 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut National de la Santé Et de la Recherche Médicale, France
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04919434.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing